Tuesday, 8 September 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· January 20, 2026

D.R. Horton, Inc., America’s Builder, Reports Fiscal 2026 First Quarter Earnings and Declares Quarterly Dividend of $0.45 Per Share

View original at finance.yahoo.com
D.R. Horton, Inc., America’s Builder, Reports Fiscal 2026 First Quarter Earnings and Declares Quarterly Dividend of $0.45 Per Share ARLINGTON, Texas, January 20, 2026--(BUSINESS WIRE)--D.R…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Sales incentives are expected to remain elevated in fiscal 2026, dependent on spring demand strength, mortgage interest rate changes, and market conditions

    80% confidence
  • Affordability constraints and cautious consumer sentiment continue to impact new home demand

    80% confidence
  • D.R. Horton's strong liquidity, low leverage, experienced operators and national scale provide significant financial and operational flexibility

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Investment Boom Meets Market Skepticism: Palantir's Contract Win vs. Stock Slide Amid Record Private AI Funding
Palantir secured the Army's high-profile TITAN AI-sensing contract and added a new executive, yet its stock fell 6% the same day — a sign that even marquee government AI wins no longer guarantee investor confidence. This tension plays out against a backdrop of surging private capital flooding into AI and AI-adjacent companies (Stability AI, Socure, Generalist AI, Emerald AI, and others), showing a bifurcated market: venture funding for AI remains red-hot while public-market sentiment toward AI-defense/enterprise plays is growing more cautious.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
General Motors Company
Both facts reference General Motors' cash position at the identical point in time (2025-12-31), both measuring FY 2025 period-end. Fact A reports $20.945 billion while Fact B reports $21.7 billion—a $755 million discrepancy (3.6% difference). Since they share the same entity, attribute, date, and fiscal period with conflicting values, this is a genuine contradiction, not a change over time. The difference is material enough to suggest either: different source data, different cash classifications (e.g., one includes equivalents/restricted cash), preliminary vs. final figures, or a data quality issue.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,278 source documents archived
Query this data → isubstrate.com